Consultant Psychiatrist at Austin Health's Brain Disorders Neuropsychiatry Program. PhD Candidate at UniMelb. MBChB FRANZCP Cert. Consul. Liaison Psych.
Joined April 2024
- Tweets58
- Following304
- Followers71
- Likes163
Pinned Tweet
Delighted and honored to announce that I have been awarded the Beverly Raphael New Investigator grant for my project on Psilocybin-Assisted Physiotherapy in Functional Neurological Disorder (FND). Grateful to RANZCP for this opportunity. #RANZCP #FND #Psilocybin #Neuroimaging
Congratulations to Dr Chiranth Bhagavan who is the recipient of the #RANZCPFoundation Beverly Raphael New Investigator grant for his project Pilot study of Psilocybin-assisted Psychiatric care & specialist Physiotherapy for refractory motor #FunctionalNeurologicalDisorder. (1/3)
Chiranth Bhagavan retweeted
What's the best(ish) predictor of therapeutic benefits on psychedelics?
INSIGHT!
Often outperforms mystical experiences.
CF: The first systematic review of insight as a core mechanism in psychedelic therapy:
osf.io/preprints/osf/5en4u
Very important study showing encouraging safety and signals for efficacy for psilocybin-assisted psychotherapy in Bipolar depression. Very exciting to see emerging treatments being studied for this condition which has very limited effective treatments at present.
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder | Psychedelic Medicine
"no evidence of treatment emergent mania, hypomania or psychosis observed in any participants."
liebertpub.com/doi/abs/10.10…
Thanks to the Victorian Biomedical Imaging Capability for this opportunity to present some of our exciting research. – at Melbourne, Victoria
#VBIC2024: Chiranth Bhagavan @UniMelb presenting on Neuroscientific mechanisms of psilocybin, motor function and functional neurological disorder
@VicBioImaging @Austin_Health @TheFlorey
Incredible week at the INA Congress. Highlights: Prof @sachdevps on covert cerebrovasvular disease and Prof Voon on impulsivity. Privileged to present more results from our #psilocybin in motor function study. Well done to the organising committee on executing a great event! – at Melbourne, Victoria
Amazing start to the International Neuropsychiatry Association Congress with the CARE #FND symposium. Highlights below. Privileged and grateful to join Prof Kanaan in his keynote on #psychedelics in FND. @Sara_Issak @Tim_R_Nicholson. Excited for the next few days. #RANZCP – at Melbourne, Victoria
Awesome to be back at the #RANZCP2024 Wellington conference. Highlights: Prof Colleen Loo on interventional psychiatry & Prof Jonathon Meyer on psychopharmacology. Privileged also to present preliminary findings from our #psilocybin and motor function pilot study.
What a thoughtful study design and interesting finding - exploring changes in Bayesian belief updating, as potential mechanisms of therapeutic response. Well done team 👏 – at Melbourne, Victoria
Computational model of the enduring effects of psilocybin, via the optimism bias, and w/fitting of behavioural data (from rats) to active inference model.
Led by @bethfisher_1, in collaboration between @Monash_M3CS, @ClaireFoldi Lab and @RyanSmith_LIBR
OA👇
Back in Wellington this week for #RANZCP NZ Conference, and Welly has been putting on an absolute stunner! Looking forward to catching up with old colleagues, mentors, and friends at the conference. #RANZCP_NZ – at Wellington City, New Zealand
Chiranth Bhagavan retweeted
Enjoyed speaking with Glenn Nielsen (@GNielsen_Physio) about the results of his Physio4FMD clinical trial published in @TheLancetNeuro for the @GreenJournal Podcast. Check it out! @FNDSociety @jonstoneneuro @AlanCarson15
Neurology Podcast: Drs. David Perez & Glenn Nielsen discuss the effectiveness of physiotherapy in treating functional motor disorder & determine the best approach for physiotherapy treatment. Listen now: bit.ly/3B15c1E
Article: bit.ly/3B48LnK
@DavidLewisPerez
Chiranth Bhagavan retweeted
‘Positive’ inter‐ictal clinical signs of functional neurological disorder are found in patients with functional / dissociative seizures.
Findings fit well with the increasingly recognized (& documented) overlap across FND subtypes. onlinelibrary.wiley.com/doi/…
📃Excited to share our protocol paper on the first study exploring #psilocybin and #motor function in healthy participants. This informs its research application in #FND and related #neuropsychiatry disorders. @GNielsen_Physio @Sara_Issak @drjrucker psychiatryonline.org/doi/10.…
Very interesting and relevant academic inquiry - likely to contribute to the factors influencing translation. Looking forward to reading updates.
Congrats @IshratHusain_ !!!
Grateful for more @CIHR_IRSC funding:
webapps.cihr-irsc.gc.ca/deci…
Grateful also to collaborate with friends and to build multi-centre RCT networks in Canada 🇨🇦
I look forward to many more @CAMHnews @KBI_UHN @UofTPsych @UHN_Research @UHN collabs!
Chiranth Bhagavan retweeted
Join us at the RANZCP 2024 New Zealand Conference to hear from these amazing speakers!
✅Professor Colleen Loo
✅Emeritus Professor Helen Hermann
✅Professor Jonathan Meyer
To review the full program, visit ranzcp2024.co.nz/program
Great podcast with @EricaSiegPsyD and Matt Butler. Exploring this novel research of #psychedelics in #FND. Touches upon the landscape of psychedelic research including placebo and expectancy confounds, among wider philosophical and clinical perspectives. Well done team! 👏
🎙️ New Podcast Episode Alert! 🎙️
It's Wednesday, and we're here to help you power through the week! 🚀 Tune in to the latest episode of the FNDS Podcast Series and get inspired by cutting-edge insights and expert discussions🧵
@FNDHope @jonstoneneuro @AlanCarson15 @FNDAction
Chiranth Bhagavan retweeted
Congratulations to Dr Andrew Gibbons (Department of Psychiatry), who has recently received the 2024 @AusNeuroSoc Illumina Neurogenomics Research Award. This will support research into better understanding a new treatment for generalised anxiety disorder: monash.edu/medicine/news/lat…
Just saw this incredible body of work investigating BOLD signal variability in FND, including longitudinal / follow-up analysis. Very intrigued by the increased SMA variability corresponding with improved outcomes at FU. 👏 @SelmaAybek
@SamWeb29 and others
sciencedirect.com/science/ar…
Very thorough review indeed, and highlighting crucial areas for improving methodological rigor in future studies. Well done team 👏
Now out in EJN! Our systematic review of neurocognitive performance in #FND spanned seizures, motor, and cognitive phenotypes. We present variable evidence for group differences, highlight common confounds, and suggest future research directions 🧐 onlinelibrary.wiley.com/doi/…
What an incredible body of work by @DrAaronFobian in developing this therapy, which integrates biopsychosocial principles and can be tailored based on an individual's needs. Excited to see this progress!
Clinical psychologist Aaron Fobian, Ph.D., created Retraining and Control Therapy for patients with functional neurological disorder. It has helped hundreds reclaim their lives and led her to develop a digital manual to expand use. @UABHeersink
Read more: go.uab.edu/45HeTO9
Chiranth Bhagavan retweeted
This is nice as it challenges the idea (that I've sometimes toyed with) that entropic brain effect is aversive. Relationship between brain entropy and valence isn't a straightforward one.
Very interesting, thanks @BellevueDoc for sharing. With many limitations to existing treatments in bipolar depression, this is a useful study to explore the safety and potential benefits of psychedelic-assisted therapy in this group. Looking forward to more studies in this space.
Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes A Nonrandomized Controlled Trial
goo.gl/scholar/YS88QH